-+ 0.00%
-+ 0.00%
-+ 0.00%

Avalyn Pharma Q3 EPS $(0.67) Beats $(0.75) Estimate

Benzinga·11/12/2026 13:38:36
Listen to the news
Avalyn Pharma (NASDAQ:AVLN) reported quarterly losses of $(0.67) per share which beat the analyst consensus estimate of $(0.75) by 10.67 percent. This is a 96.71 percent increase over losses of $(20.34) per share from the same period last year.